EBRIGHT RICHARD H has a total of 17 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and organic fine chemistry are FINNISH IMMUNOTECHNOLOGY LTD, EUTROPICS PHARMACEUTICALS INC and OREGON HEALTH & SCIENCES UNIVE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Pharmaceuticals | |
#5 | Environmental technology | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Ebright Richard H | 17 |
#2 | Degen David | 2 |
#3 | Severinov Konstantin | 2 |
#4 | Ebright Yon W | 2 |
#5 | Mukhopadhyay Jayanta | 2 |
#6 | Semenova Ekaterina | 1 |
#7 | Shen Juan | 1 |
#8 | Zhang Yu | 1 |
#9 | Ebright Katherine Y | 1 |
#10 | Ebright Yon | 1 |
Publication | Filing date | Title |
---|---|---|
US2014206602A1 | Bipartite inhibitors of bacterial RNA polymerase | |
US2013296421A1 | Arylpropionyl-alpha-pyrone antibacterial agents | |
US2013289128A1 | Arylpropionyl-triketone antibacterial agents | |
WO2007106472A2 | Non-mccj25-related lariat-peptide inhibitors of bacterial rna polymerase | |
US2007196886A1 | Target And Method For Inhibition Of Bacterial Rna Polymerase Minimized Derivatives Of Peptide Antibiotic Mccj25 | |
WO2005001034A2 | Rna-exit-channel: target and method for inhibition of bacterial rna polymerase |